Shared on 16 Nov 25
Fair value Increased 2.27%CHG: Rising Profit Margins Are Expected To Drive Future Share Performance
Analysts have raised their fair value estimate for Chemring Group from £6.16 to £6.30. This reflects improved profit margin expectations, despite slightly lower projected revenue growth.
Shared on 01 Nov 25
Chemring Group: Analyst Price Target Holds Steady on Unchanged Fair Value Outlook Analysts have maintained their price target for Chemring Group at £6.16. They note that stable profit margin and revenue growth forecasts, along with only minor shifts in discount rate and forward price-to-earnings ratios, support the unchanged valuation.
Shared on 18 Oct 25
Narrative Update on Chemring Group Analyst Price Target Analysts have maintained their fair value estimate for Chemring Group at £6.16 per share. They note only marginal adjustments to key model inputs and a steady outlook for long-term growth and profitability.
Shared on 04 Oct 25
Fair value Increased 6.51%Analysts have raised their price target for Chemring Group from £5.78 to £6.16. This change is attributed to higher projected revenue growth, which is expected to offset a modest dip in profit margin forecasts.
Shared on 29 Jul 25
Fair value Increased 17%The significant upward revision in Chemring Group’s consensus price target is primarily driven by stronger revenue growth forecasts and an increase in expected future P/E multiples, resulting in a higher fair value estimate of £5.78. What's in the News Completed repurchase of 11,152,161 shares (3.99%) for £37 million under the share buyback program.
Shared on 01 May 25
Fair value Increased 1.86%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 2.02%AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 19 Mar 25
Fair value Increased 5.54%AnalystConsensusTarget has increased revenue growth from 10.2% to 11.3%, increased discount rate from 6.8% to 7.5% and decreased shares outstanding growth rate from -0.0% to -0.0%.